bortezomib,dexamethasone,lenalidomide
takeda
['determination']
determination trial did not change myeloma practice yet! #asct is to be offered in the first line. what we need is an mrd-driven randomized trial ? #asco22 
BMT fellow #Tx & #CARTcells @MayoClinic | Previous Hematology-Oncology Fellow @AUB_Lebanon | EBMT Young Ambassador 2018 | My tweets are my own